Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Investment firm Deerfield Management is partnering with Amazon Web Services to build AI infrastructure across its healthcare and life sciences portfolio. AWS becomes a preferred AI provider, giving select Deerfield portfolio companies access to cloud tools, agentic AI services, and technical training. The goal: accelerate AI-driven transformation in drug discovery, care delivery, and operations.
Investment firm Deerfield Management is joining forces with Amazon Web Services (AWS) to build a shared AI and cloud infrastructure across its healthcare and life sciences ecosystem. Under the deal, AWS becomes Deerfield's preferred AI provider, with select portfolio companies gaining access to generative AI tools, large-scale model training, inference optimization, and healthcare-specific managed services.
The partnership goes beyond just portfolio companies — Deerfield's own internal teams, including its data and AI arm (Deerfield Intelligence) and its R&D engine (Deerfield 3DC), will also tap into AWS technology to scale proprietary healthcare AI products. One early example: Ascertain, a Deerfield-backed company, is already using AWS infrastructure to automate administrative workflows like prior authorization and case management.
Key Takeaways:
Why it matters: As AI adoption in healthcare accelerates, infrastructure partnerships like this one could help startups move from development to real-world deployment faster — potentially reshaping how care is delivered and how drugs are discovered at scale.
